Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent

OBJECTIVE: We aimed to evaluate the efficacy and safety of the three dipeptidyl peptidase 4 (DPP-4) inhibitors (vildagliptin, sitagliptin, and linagliptin) as add-on therapy in Chinese patients with type 2 diabetes mellitus (T2DM)inadequately controlled on dual combination of insulin and metformin o...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetol Metab Syndr
Hlavní autoři: Tang, Yun-Zhao, Wang, Gang, Jiang, Zhen-Huan, Yan, Tian-Tian, Chen, Yi-Jun, Yang, Min, Meng, Ling-Ling, Zhu, Yan-Juan, Li, Chen-Guang, Li, Zhu, Yu, Ping, Ni, Chang-Lin
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2015
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4616160/
https://ncbi.nlm.nih.gov/pubmed/26500706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-015-0087-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky